|
Lisa Nash, RN, a neonatal intensive care nurse from
Denver, knew early on that there were problems with
her pregnancy. But even after multiple ultrasounds and
an amniocentesis, no one could tell her exactly what
was wrong with her baby.
When Molly was born, her deformities became evident.
She was missing both her thumbs, her right arm was shorter
than her left and she had two heart malformations. Still,
even after her birth, Molly had no diagnosis.
Nash and a co-worker carefully reviewed the book Smith's
Recognizable Patterns of Human Malformations by Kenneth
Lyons Jones, MD, and they identified three possible
diagnoses for Molly. The most likely and final diagnosis
was Fanconi's anemia (FA), a rare genetic condition
that leads to aplastic anemia and bone marrow failure.
With the diagnosis of FA, Nash and her husband, Jack,
began to research options to save their daughter's life.
Molly would need a bone marrow transplant. An unrelated
marrow donor carried only a 19 percent to 20 percent
success rate. Providing the closest donor match for
Molly meant the Nashes would need to have another child.
Unfortunately, the Nashes had a 25 percent chance of
having another baby with FA. They did not want another
child to experience what Molly was going through.
At an FA conference, the Nashes heard a physician say
it might be possible to conceive with in vitro fertilization
and test the embryos at eight cells for FA. He also
said it may be possible to screen for embryos that had
the same marrow as Molly.
Stem cell research, cloning, genetic research and embryonic
screening are headline topics. As technology grows,
nurses will find they encounter more patients with questions
about what technology is available. Like the Nashes,
these patients will be searching for options.
Behind the debate
With Molly becoming sicker and more dependent on blood
transfusions to live, the Nashes had gone through four
unsuccessful attempts at transplanting embryos that
were both free of FA and matches to Molly's bone marrow.
On the fifth attempt, Lisa became pregnant and gave
birth to Adam, a healthy baby boy. Adam's stem cells
were taken from the placenta and transfused into Molly,
saving her life.
"I had been on bed rest for 24 weeks. We'd moved
to a new state with a 7-day-old baby who had just been
circumcised. We didn't know if our daughter was going
to live or die and the media was in our face,"
Nash said. "People have to step back and say, 'If
this were my child, would I be at the head of the line?'
When my husband and I decided what to do, we didn't
do it for the pope's approval or the world's approval
or disapproval; we did it so Molly would have a brother
or sister and outlive us."
The Nash family story demonstrates that behind every
practice in health care that can be held up for ethical
debate and scrutiny lies real families, facing real
obstacles and trying to do what they believe is best.
As technology grows, so does the field of bioethics.
Genetic testing
Patients at risk of transmitting a genetic disorder
to a child now have several technological options. They
may use prenatal diagnosis via amniocentesis, chorionic
villus sampling and ultrasonography. They may choose
to conceive a child through donor gametes and donor
embryos like the Nashes, or they may use preimplantation
genetic diagnosis. As testing options increase, nurses
will need to know the treatments available and be able
to respond to patients' inquiries.
Rebekah Hamilton, MSN, RN, a doctoral student at the
University of Wisconsin-Madison, is doing research on
predictive genetic testing. The practice may be used
for parents considering conceiving or individuals looking
for confirmation about their own genetic predispositions.
"Genetic testing creates a very different picture
of an individual. You are testing the whole family.
It certainly changes our concept of informed consent.
Informed consent is based on autonomy and one person's
right to know that their genetic future supersedes other
family members' right not to know," Hamilton said.
There are misconceptions about genetics within the
lay public and Hamilton believes that nurses need to
be informed about the process of genetic research and
know what is clinically available to patients. The steps
individuals take after undergoing personal genetic testing
are not always known. The ability to screen for genetic
conditions exceeds the ability to treat these conditions.
"When patients ask questions about genetic testing
and options, nurses need to have educated answers,"
Hamilton said.
Stem cell research
Stem cell research is a headline topic of late and
one that elicits strong opinions. While few nurses work
with stem cells, many RNs encounter questions about
the potential treatments that may arise from stem cell
research.
"Like many issues in medicine, some nurses are
positive about this technology because they see the
potential for impacting diseases such as Alzheimer's
and Parkinson's in a positive way. Others are much more
hesitant because the technology is seen as changing
the nature of a human being and what this may mean for
how we understand ourselves as people is very uncertain,"
said Joan Liaschenko, Ph.D., RN, associate professor
at the University of Minnesota School of Nursing Center
for Bioethics.
Stem cells are unique-they are "blank" cells
that have the potential to develop into any type of
cell in the body. Scientists harvest these cells before
they become differentiated so they can coax the cell
to grow into a specific type of cell. These cells could
potentially be used to grow nerve cells to repair brains
damaged by Alzheimer's or Parkinson's or to replace
injured spinal cord cells.
In the case of Molly Nash, stem cells from Adam's placenta
became Molly's bone marrow.
"Embryonic cells have two potentials. The first
is to divide infinitely in a petri dish and the second
is to make a specific type of cell," said Richard
Furnaletto, Ph.D., MD.
"Embryonic cells can become many things. We know
this for a fact because embryonic cells differentiate
and create a human being. However, most adult stem cells
can divide only 60 times and have already started to
become a specific type of cell," said Furnaletto,
who is scientific director of the Juvenile Diabetes
Research Fund. The group supports both adult and embryonic
stem cell research as the debate continues as to what
types of cells perform best in research.
Cloning cells
Martha Ogburn, MS, RN, acting director of the Eastern
Shore Pregnancy Center in Salisbury, Md., was so interested
with the topic of cloning and fetal tissue that she
provided commentary on the radio and in newspaper articles
and wrote a medical thriller.
Ogburn believes that technology should not be used
just because it is available.
"I was medically trained in a scientific arena
and was not really aware of philosophy," she said.
"Nurses need to be able to think through things
and take arguments apart and decide whether the arguments
are valid. Nurses need to do their homework, read and
digest information and make it their own."
As the field of bioethics grows, nurses will need to
develop strategies for approaching bioethical issues.
Sister Mary Margaret Mooney, MSN, dean of nursing at
Clarke College in Dubuque, Iowa, said, "Nurses
need to develop a disciplined, intellectual approach
to biotechnology issues. We need to be clear on our
role in the decision-making process.
"Our society tends to be quick to make rules or
to go to an extreme and say there are not rules regarding
situations with which we are uncomfortable. We need
to be clear on what value a particular rule is intended
to protect."
Advances in technology will continue to change the
way medicine is practiced and, inevitably, bioethical
dilemmas will grow. In the case of the Nashes, through
technology one life was saved and another was created.
But not all ethical dilemmas will have such a positive
outcome.
"Nurses must always remember that the profession
they have chosen is an ethical activity with a technical
aspect," Mooney said. "The glamour of the
technology must never be permitted to gloss over the
value and dignity of the person as a person."
Contact
Carol Lindsay at carol@lindsay.net.
|